Tags » Nanomedicine

Nanomedicine: Nanotechnology, Biology, and Medicine Publishes Preclinical Data on Arch Therapeutics’ AC5 Surgical Hemostatic Device(TM)

Independent Peer-Reviewed Study Concludes That AC5(TM) Quickly Stops Bleeding in Animals Treated With the Anticoagulant, HeparinWELLESLEY, MA, Feb 19, 2015 (Marketwired via COMTEX) Positive data from an independent third-party research group study sponsored by Arch Therapeutics, Inc. 109 more words

Nanomedicine: Nanotechnology, Biology, and Medicine Publishes Preclinical Data on Arch Therapeutics’ AC5 Surgical Hemostatic Device(TM) | Publicwire


Nanomedicine: Nanotechnology, Biology, and Medicine Publishes Preclinical Data on Arch Therapeutics’ AC5 Surgical Hemostatic Device(TM)
http://bit.ly/1CNrB7S

A Novel Theranostic Treatment for Glioblastoma

Glioblastoma is an intracranial neoplasm that is usually widespread among adults between ages of 45 to 70 years. In 2010, out of 22,000 Americans only 8,860 were reported to survive from brain and central nervous system cancers. 852 more words

Thirteen Word Story: Eat The World

NEVER GAIN WEIGHT: NANOSCULPTORS DESTROY FAT

The third world starved like never before.

Science Fiction

Possible Magnetic Resonance Signal Due to the Movement of Counterions around a Polyelectrolyte with Rotational Symmetry

Read  full  paper  at:

http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53767#.VNHXLSzQrzE

Experimental, theoretical and computational studies revealed that the characteristic time scales involved in counterion dynamics in polyelectrolytes systems might span several orders of magnitude ranging from subnanosecond times to time scales corresponding to acoustic-like phonon mode frequencies, with an structural organization of counterions in charge density waves (CDWs). 604 more words

Nanomedicine and Theranostics: What Do We Know?

A nanomedicine of twenty first century has seen a revolution in the treatment of patients with the use of nanoparticles. Moving into more specialized and personalized medicine, researchers have designed theranostic systems to target tumour cells of patients according to their genetic and biological makeup. 433 more words

CTSC Seed-Funding Awardee Michelle Bradbury, MD, PhD, and Colleagues Develop Innovative Approach to Imaging Cancer

In a recent issue of the journal Science and Translational Medicine, researchers Michelle S. Bradbury, MD, PhD, and Ulrich Wiesner, PhD, and their teams, published the… 924 more words

Weill Cornell CTSC